Thr504

Site Information
LLsVRTStIKNHEFI SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 11139168

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 2 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 2 ) , oocyte ( 1 )

Upstream Regulation
Regulatory protein:	KCNIP2 (human) ( 1 )
Treatments:	phorbol_ester ( 1 )

Downstream Regulation
Effects of modification on Kv4.3:	activity, inhibited ( 1 )

References
1	Abbott GW (2017) β Subunits Control the Effects of Human Kv4.3 Potassium Channel Phosphorylation. Front Physiol 8, 646 28919864 Curated Info
2	Zhou J (2009) CST Curation Set: 7636; Year: 2009; Biosample/Treatment: cell line, HeLa/untreated; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS/T) (23C8D2) Rabbit mAb Cat#: 10001, PTMScan(R) Phospho-Akt Substrate Motif (RXRXXS/T) Immunoaffinity Beads Cat#: 1979 Curated Info

References

Abbott GW (2017) β Subunits Control the Effects of Human Kv4.3 Potassium Channel Phosphorylation. Front Physiol 8, 646
28919864 Curated Info

Zhou J (2009) CST Curation Set: 7636; Year: 2009; Biosample/Treatment: cell line, HeLa/untreated; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS*/T*) (23C8D2) Rabbit mAb Cat#: 10001, PTMScan(R) Phospho-Akt Substrate Motif (RXRXXS*/T*) Immunoaffinity Beads Cat#: 1979
Curated Info